Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Phagosome	4/152	2.3172889593808534e-05	0.0013208547068470865	35.67567567567568	-94.73234202435842	CLEC7A;MBL2;SFTPA2;TLR4
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0016336843180154406	55.34101382488479	-100.98537671170521	IL4;IL4R;TLR4
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.0038249954094541037	35.589285714285715	-70.42440314178907	FCER2;IL4;IL4R
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.04042483337909309	27.006756756756758	-34.90410589940028	SFTPA2;TLR4
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.04042483337909309	26.643333333333334	-34.49723066158141	IL4;TLR4
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.04042483337909309	11.412915851272016	-23.74866982495136	CCL17;IL4;IL4R
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.04042483337909309	21.67391304347826	-28.742216935482162	CCL17;IL4
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.04042483337909309	22.16111111111111	-29.32328202848766	IL4;IL4R
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.041223392140870854	19.524509803921568	-26.130280011490946	CCL17;CLEC7A
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.041223392140870854	18.95952380952381	-25.42995427691617	IL4;IL4R
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.041223392140870854	9.422466422466423	-19.140881053489387	IL4;IL4R;TLR4
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.07687010676111444	12.35625	-16.748364182562245	IL4;IL4R
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.08661819227381078	11.081460674157304	-14.950240051620256	CLEC7A;TLR4
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.08817245334482264	10.536096256684491	-14.167050995225416	CLEC7A;TLR4
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.12064105916568432	8.519565217391305	-11.194266119915625	MBL2;TLR4
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.13445060941021428	29.77037037037037	-16.126223630092912	IL4
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.15451383102786836	24.117117117117118	-13.560364723090352	IL4
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.16349028042403987	18.962174940898347	-11.032973182262484	IL4
KEGG_2021_Human	Vibrio cholerae infection	1/50	0.060233261208856796	0.16349028042403987	18.183673469387756	-10.63265628196324	CFTR
KEGG_2021_Human	ABC transporters	1/45	0.05436047130022726	0.16349028042403987	20.262626262626263	-11.690056551619103	CFTR
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.16349028042403987	18.183673469387756	-10.63265628196324	TLR4
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.16514754791699915	17.128205128205128	-10.081098986019231	IL4
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.16951310116791793	15.896825396825397	-9.424000900813787	TLR4
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.18732998145890306	9.425531914893616	-5.678293992521663	MBL2
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.18732998145890306	8.94388327721661	-5.375723879218761	CCL17
KEGG_2021_Human	Gastric acid secretion	1/76	0.09024597396088518	0.18732998145890306	11.841481481481482	-7.141387005986298	CFTR
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.18732998145890306	13.26865671641791	-7.96724592924887	IL4
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.18732998145890306	8.592233009708737	-5.152341092635986	TLR4
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.18732998145890306	9.632850241545894	-5.8073541800756905	TLR4
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.18732998145890306	8.592233009708737	-5.152341092635986	TLR4
KEGG_2021_Human	Complement and coagulation cascades	1/85	0.10043221696214563	0.18732998145890306	10.56084656084656	-6.37671991533167	MBL2
KEGG_2021_Human	Pancreatic secretion	1/102	0.11939326812281527	0.18732998145890306	8.764576457645765	-5.262086311101535	CFTR
KEGG_2021_Human	Bile secretion	1/90	0.10604677818396174	0.18732998145890306	9.961298377028713	-6.010407578745034	CFTR
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.18732998145890306	8.592233009708737	-5.152341092635986	IL4
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.18732998145890306	8.764576457645765	-5.262086311101535	TLR4
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.18732998145890306	8.764576457645765	-5.262086311101535	TLR4
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.18732998145890306	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.190552542469193	7.964964964964965	-4.748494648054986	TLR4
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.190552542469193	8.189300411522634	-4.893732148578802	TLR4
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.19335084305060599	7.4220354808590105	-4.393179099544486	CFTR
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.19335084305060599	3.5628544423440456	-3.410136075895621	IL4;IL4R
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.21132909582261403	6.480392156862745	-3.763669230249352	TLR4
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.21132909582261403	6.384863123993559	-3.698840756963446	TLR4
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.23240087986172991	5.562587904360056	-3.1333425612983894	TLR4
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.23240087986172991	5.456866804692892	-3.0596637281364782	TLR4
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.23495717443103262	5.224867724867725	-2.8972129419331236	CFTR
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.23495717443103262	5.131254061078622	-2.8313674486945275	TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	1/181	0.20287322552436027	0.24091195531017784	4.869135802469136	-2.6461154603833723	TLR4
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.24616267877061626	4.283224400871459	-2.2275706216550177	TLR4
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.24616267877061626	4.5823152995927865	-2.441961042053517	CCL17
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.24616267877061626	4.137440758293839	-2.12256354972075	TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.24616267877061626	4.462585034013605	-2.3563138595912863	TLR4
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.24616267877061626	4.3488114980652295	-2.274707784911856	FCER2
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.24616267877061626	4.077881619937695	-2.079575623138921	TLR4
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24616267877061626	4.058397932816537	-2.065502377074288	CFTR
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2689494049142217	3.547845804988662	-1.6951894904190261	TLR4
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.2689494049142217	3.503584229390681	-1.6629804039719844	TLR4
